Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP840148.RAFrU3BLTJt8l8HxyIin3Z-T_fE93a3IRyGT2QBDeGHds130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP840148.RAFrU3BLTJt8l8HxyIin3Z-T_fE93a3IRyGT2QBDeGHds130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP840148.RAFrU3BLTJt8l8HxyIin3Z-T_fE93a3IRyGT2QBDeGHds130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP840148.RAFrU3BLTJt8l8HxyIin3Z-T_fE93a3IRyGT2QBDeGHds130_provenance.
- befree-2016 importedOn "2016-02-19" NP840148.RAFrU3BLTJt8l8HxyIin3Z-T_fE93a3IRyGT2QBDeGHds130_provenance.
- NP840148.RAFrU3BLTJt8l8HxyIin3Z-T_fE93a3IRyGT2QBDeGHds130_assertion wasGeneratedBy ECO_0000203 NP840148.RAFrU3BLTJt8l8HxyIin3Z-T_fE93a3IRyGT2QBDeGHds130_provenance.
- NP840148.RAFrU3BLTJt8l8HxyIin3Z-T_fE93a3IRyGT2QBDeGHds130_assertion wasDerivedFrom befree-2016 NP840148.RAFrU3BLTJt8l8HxyIin3Z-T_fE93a3IRyGT2QBDeGHds130_provenance.
- NP840148.RAFrU3BLTJt8l8HxyIin3Z-T_fE93a3IRyGT2QBDeGHds130_assertion SIO_000772 20852404 NP840148.RAFrU3BLTJt8l8HxyIin3Z-T_fE93a3IRyGT2QBDeGHds130_provenance.
- NP840148.RAFrU3BLTJt8l8HxyIin3Z-T_fE93a3IRyGT2QBDeGHds130_assertion evidence source_evidence_literature NP840148.RAFrU3BLTJt8l8HxyIin3Z-T_fE93a3IRyGT2QBDeGHds130_provenance.
- NP840148.RAFrU3BLTJt8l8HxyIin3Z-T_fE93a3IRyGT2QBDeGHds130_assertion description "[MMP1 2G carriage (P = 0.0008), TIMP4 lower serum levels (P = 0.02), treatment with stavudine (P < 0.0001), treatment with zidovudine (P = 0.006) and absence of hepatitis C virus coinfection (P = 0.002) were associated with lipodystrophic syndrome by logistic regression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP840148.RAFrU3BLTJt8l8HxyIin3Z-T_fE93a3IRyGT2QBDeGHds130_provenance.